Refine by
Biopsy Needle Articles & Analysis
9 news found
6 Using an MRI-first strategy may mean additional costs associated with MRI scans, but these can be offset by the reduction in biopsies, biopsy cores and over treatment.2, 3, 4,5, 6 In the Callender study, MRI-first biopsies resulted in 0.9% fewer deaths from cancer, 14.9% fewer overdiagnosis and 33.8% fewer biopsies. ...
When comparing the results of the miR Sentinel® Prostate Cancer Test to systematic core needle biopsy in men presenting with initial suspicion of prostate cancer, the latest validation study demonstrated a 93% concordance between the two methods of screening and detection regarding the classification of clinically significant cancer. ...
The current standard of care relies on measuring changes in serum creatinine levels, which has poor sensitivity and specificity for detecting kidney transplant rejection, and can rise and fall due to numerous factors, leading to challenges making therapeutic decisions in a timely manner. Utilization of needle biopsy procedure and histology is more accurate; ...
The key features of this landmark technology which moves flat 2 dimensional, compressed images away from mammography include: the elimination of painful compression; a common complaint of conventional mammography for the first time, presenting true, Isotropic 3-dimensional images in a natural undistorted view from compressing breast tissue multiplanar reconstruction allowing coregistration ...
These concerns drive many men to undergo repeat biopsy. In fact, the Surveillance, Epidemiology, and End Results (SEER) data indicates that ~12% of men with a prior negative biopsy have a repeat biopsy within 1 year and 44% of men younger than 70 years old have a repeat biopsy. The EPI test was previously validated in patients ...
The article, entitled “Impact of EUS-guided microforceps biopsy and needle-based confocal laser endomicroscopy on the diagnostic yield and clinical management of pancreatic cystic lesions” was published in Gastrointestinal Endoscopy (2019, DOI: 10.1016/j.gie.2019.12.022). ...
Nevertheless, large-scale gene expression profiling from biopsy samples is not currently feasible,” said Thomas Stavros, MD, Chief Medical Officer of Seno Medical. ...
The University of Arizona has licensed the design for a next-generation needle biopsy instrument that utilizes electrosurgery and electrocautery to safely increase tissue sample volumes in minimally invasive biopsy procedures. ...
The disease has no symptoms that most people notice, and testing for it requires a needle biopsy of the liver, so it often goes undetected. Current estimates indicate that between 6 and 17 percent of Americans have NASH. ...